2-for-1 biomarker and tumor suppressor; Biomarkers for early-stage Parkinson's;

> Researchers at the University of California, San Diego School of Medicine have found a possible two-for-one deal: an antibody that can be used as a biomarker for cancer risk and also a treatment for suppressing tumor growth. UC San Diego news release

> Activation of biomarker linked with improved survival among obese patients with colorectal cancer. More here

> Scientists detect several biomarkers to screen active drugs for Batten disease, a rare disease that begins in childhood with visual impairment and ends in failure of all motor abilities. Item

> Biomarkers for detecting the early stages of Parkinson's disease could accelerate development of new treatments. Abstract

> GVK Biosciences, an Indian contract research organization, has extended its agreement with the Food and Drug Administration for the U.S. agency to access its biomarker database. The FDA uses the the information to develop its guidance on biomarker qualification. Item

> The Wisconsin Alumni Research Foundation is seeking commercial partners interested in developing genes that could be used as biomarkers for prostate cancer screening. Details

> Proteins in leaked amniotic fluid could be used as biomarkers for prelabor rupture of membranes. Abstract

Suggested Articles

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.